Trials / Conditions / Recurrent Primitive Neuroectodermal Tumor
Recurrent Primitive Neuroectodermal Tumor
4 registered clinical trials studyying Recurrent Primitive Neuroectodermal Tumor.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer NCT04521946 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or R NCT02444546 | Mayo Clinic | Phase 1 |
| Completed | Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurren NCT01217437 | National Cancer Institute (NCI) | Phase 2 |
| Unknown | Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CN NCT00983398 | OHSU Knight Cancer Institute | Phase 1 / Phase 2 |